“…Binding of viral components triggers a downstream signaling cascade, beginning with the activation of one or more of the three kinds of receptors: retinoic-acid inducible gene-I (RIG-I)-like receptors (RLRs); melanoma-differentiation-associated-gene 5 (MDA5) in the cytoplasm; and nucleotide oligomerization domain (Nod)-like receptors (NLRs) and Toll-like receptors (TLR; e.g., TLR3, TLR7 and TLR8) in endosomes [ 132 , 133 , 134 , 135 ]. Activation of downstream adapter molecules with kinase activity (e.g., NEMO, IKKα, IKKβ; TBK, IKKε) activates transcription factors (e.g., IRF3 and IRF7) and NF-κB in a cell-type-specific manner [ 132 , 133 ]. IRF1, IRF3, IRF5 and IRF7 all restrict WNV replication; however, IRF5 plays a non-redundant, immunomodulatory role in shaping the early immune response events via production of pro-inflammatory cytokines in the lymphoid tissues, but not type I interferons, and also affects the trafficking and activation of immune cells entering the draining lymph node [ 136 ].…”